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Diabetes mellitus is what many people refer to simply as diabetes. It 
affects thousands of people directly and is an indirect cause of blindness, 
renal failure, myocardial infarction, and stroke. The symptoms of diabetes 
are increased thirst, appetite, fatigue, urination, and weight loss (Wilson, 
J., 1985). A common symptom for male diabetics is impotence. It is 
estimated that 37-55% of male diabetics become impotent (Brotherton, J., 
1976). Diabetes is gentically inherited .and is caused by a lack of 
functioning beta cells of the pancreas. Deficient beta cells result in a 
lack of insulin and therefore a low insulin to glucose ratio. Diabetes has 
been referred to as a disease of starvation in the midst of plenty. The 
tissues of the body are literally starved for glucose because without 
insulin, the glucose cannot be used by the tissues. The glucose content in 
the blood increases while the utilization of glucose by peripheral tissues 
decreases. Diabetes also results in a decrease in muscle anabolism and an 
increase in ketogenesis. The use of ketone bodies for energy, however, is 
decreased in diabetes. Diabetes causes adipose tissue triglycerides to be 
mobilized at an increased rate. These triglycerides are converted to free 
fatty acids, thus increasing the level of free fatty acids in the plasma 
(Berne, 1988). It is this last symptom of diabetes that will be the topic of 
th is experiment. 
Free fatty acids are a common source of energy for the body. They can 
go through the citric acid cycle in order to produce ATP for energy or they 
can be converted into ketone bodies and used for energy ( Fox, Stuart Ira, 
1984). Excess free fatty acids are carried by the blood to the liver. In the 
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liver, free fatty acids are re-esterified and secreted back into circulation 
as very low density lipoproteins (VLDL) ( Crepaldi, G. 1985). Estrogens in 
diabetics show an increase in VLDL whereas testosterone shows a 
decrease in VLDL. This may be due to testosterone indirectly inhibiting 
the uptake of free fatty acids into the liver ( Brotherton, J., 1976). 
Testosterone regulates the activity of lipoprotein lipase and the lipase 
inversely regulates VLDL synthesis (Crepaldi, G., 1985). 
Testosterone itself also has an effect on fatty acid mobilization. It is 
possible that testosterone acts synergistically with diabetes and 
therefore enhances the symptoms of diabetes. It is the purpose of this 
study to investigate the effects of testosterone on diabetic male rats. 
This research project was based on the results of a previous 
experiment. Due to the high rate of impotence found in male diabetic 
patients, testosterone was given to diabetic male rats, in an effort to 
reverse the diabetic effects. Testosterone, being an anabolic sex steroid, 
was expected to increase body weight and hopefully reverse the abnormal 
sex behavior. The opposite of the expected results were observed in the 
previous experiment. The animals lost weight, at a rate faster than the 
diabetic animals not receiving testosterone, and the abnormal sex behavior 
was not reversed. In other words, the exogenous testosterone appeared to 
make the animals more diabetic. Since this was completely unexpected, 
possible explanations were sought, and thus the basis for this experiment. 
In this experiment, four subject groups of rats were set up. Group 1, 
STZ, was a diabetic group receiving oil injections, and group 2, STZ + T, 
was a diabetic group receiving testosterone injections. Group 3 served as 
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the control group and received oil, and group 4 was normal and received 
testosterone injections. The subcutaneous injections were given daily and 
the amount given was based on the individual animal's body weight. All 
animals were weighed on March 23 and groups 1 and 2 were given 
intraperitoneal streptozotocin, STZ, injections at a dose of 50 mg/kg of 
body weight. The STZ rendered those animals diabetic. Animals from 
groups 3 and 4, were injected only with a citrate buffer, in order to 
maintain consistency. The animals were all weighed every other day 
thereafter, in order to adjust the testosterone dosage for changing body 
weight. Both STZ and testosterone dosages are listed in table 1. Groups 1 
and 3 received daily subcutaneous sesame seed oil injections, while 
groups 2 and 4 received daily subcutaneous testosterone injections. The 
testosterone was diluted with the sesame seed oil so that the dose was 
0.5 ug/gm of body weight. Animals were injected daily beginning on March 
24 and proceeding to April 9, 1989. For one week during the experiment, 
food and water intake was measured. Then, on April 10 the animals were 
sacrificed by decapitation and the following were collected: blood, brain, 
heart, liver, pituitary, spleen, kidneys, adrenal glands, epididymal fat pad, 
gastrocnemius muscle, seminal vesicles, and testis. The blood samples 
were used to measure glucose levels of the animals, using the Sigma 
glucose test. All organs were weighed for wet weight. Then all organs, 
except for pituitaries and brains, were dried in an oven in order to obtain 
dry weights. 
RESULTS 
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The body weights of all the animals were recorded every other day. As 
was previously mentioned, the diabetic animals that were receiving 
testosterone injections, lost more body weight than any other group. The 
normal rats receiving testosterone gained more weight than any other 
group. These results are easily seen in graph 1. On day 1 the four groups 
were not significantly different in body weights (p=0.3377), but on day 5 
of the experiment, the body weights between the diabetic and control 
groups were significantly different (p=0.0001). By day 9 of the study, all 
four groups were significantly different from each other (p=0.0001). This 
is consistent with the data which was recorded in the previous study 
(graph 2). 
The food and water intake was measured for five days. The average 
food intake of the diabetic rats was 190% higher than the non-diabetic 
rats. The water intake of the diabetic animals (groups 1 and 2) was 505% 
higher than the non-diabetic animals. Group 4, Ctrl + T, had a slightly 
higher water consumption, than the control (group 3), but it was not 
significant. The increased water and food consumption of the diabetic 
animals was expected due to the clinical fact that diabetics normally 
consume large quantities of fluids and increased amounts of food. The 
diabetic rats were also observed to be urinating more than the 
non-diabetic rats. These results are depicted in graphs 3 and 4. 
Glucose tests were run on the blood samples. This is also used 
clinically to diagnose diabetes. The average glucose level for group 1, 
STZ, was 498.3 mg/ml and for group 2, STZ + T, was 536.5 mg/ml. The 
average glucose levels for group 3, Ctrl, and group 4, Ctrl + T, were 56.2 
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mg/ml and 67.4 mg/ml respectively. The diabetic groups, 1 and 2, have a 
significantly higher plasma glucose concentration. This can be seen in 
graph 5. 
The organ weights were measured for both wet and dry weights. For 
the wet weights, the heart, liver, and adrenal glands did not have any 
significant differences. The following organs were significantly different 
(p<O.05): pituitary, kidneys, spleen, skeletal muscle, epididymal fat pad, 
testis, and seminal vesicles. The dry organ weights were not significantly 
different for the heart, liver, kidneys, adrenal glands, and testis. The 
spleen, skeletal muscle, epididymal fat pad, and the seminal vesicles were 
all significantly different except between the two diabetic groups (STZ 
and STZ + T). These results can be seen in graphs 6-16. 
DISCUSSION 
The increased rate of body weight loss in the diabetic, testosterone 
treated rats, group 2, may be due to synergistic actions of diabetes and 
testosterone on free fatty acids (FFA). Free fatty acids are a main source 
of energy in the body. They contribute approximately 41-49 % of the 
energy used by the striated muscle alone ( Reiser, Peter. 1967). In 
diabetes, due to the fact that the glucose utilization by striated muscles 
is inhibited by the lack of insulin, the muscles depend more heavily on free 
fatty acids as their energy source ( Brotherton, J. 1976). There are 
several mechanisms which cause an increase in the concentration of free 
fatty acids in the blood. These are due to the actions of both testosterone 
and diabetes on free fatty acids. 
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Normally testosterone causes an increased mobilization of fatty acids 
from adipose tissue. The fatty acids then bind to albumin in the blood and 
are carried to the skeletal muscles, where they will be used as an energy 
source. The free fatty acids are then used to increase the muscle mass 
(Berne, 1988). This process is normally aided by insulin. The lack of 
insulin, as in diabetes, inhibits the muscles from taking up the free fatty 
acids from the bloodstream. Therefore, the concentration of FFA in the 
blood would increase due to the exogenous testosterone ( Brotherton, J. 
1976). 
Testosterone also regulates the local activity of lipoprotein lipase. 
This lipase accelerates the mobilization of lipids into free fatty acids. 
The increase in testosterone, due to the exogenous injections, would cause 
and increase in the activity of the lipoprotein lipase, and thus the increase 
of free fatty acids in the blood. Lipoprotein lipase activity is also 
inversely related to the synthesis of VLDL ( Crepaldi, G. 1985). The 
increased testosterone accounts for the decreased VLDL in the plasma. 
Estrogens, which are not known to affect the lipoprotein lipase, show an 
increase in VLDL ( Brotherton, J. 1976). These increased levels of free 
fatty acids, due to testosterone, may enhance the effects of diabetes. 
The potentiation of diabetes by testosterone, has been noted in other 
studies. S. G. Paik noted that testosterone enhances the induction of 
diabetes in genetically susceptible mice, and that estrogens inhibit the 
induction of diabetes by streptozotocin ( Paik, S. G., 1982). Another study 
by R. A. Kava, stated that in men and women with matched body percent 
fat, men were more susceptible to developing diabetes. This sexually 
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dimorphic response to diabetes may be due to the ratio of androgens to 
estrogens in the genetically susceptible animal ( Brotherton, J., 1976). 
This may prove to be the reason that males more commonly develop 
diabetes. 
Diabetes in itself also causes an increase in the plasma level of free 
fatty acids through several mechanisms. One mechanism by which 
diabetes causes increased plasma free fatty acids is a higher turnover 
rate of free fatty acids. Insulin inhibits the mobilization of free fatty 
acids in two ways. First, the action of insulin to move glucose into the 
cell produces a substance called glycerophosphate. Glycerophosphate is 
used by the body to re-esterify free fatty acids. The second mechanism is 
also due to the actions of insulin. Insulin inhibits many adipokinetic 
hormones. Some of these hormones are epinephrine, norepinephrine, 
adrenocorticotrophin, glucagon, and cortisol. Without insulin these 
substances would enhance the rate of mobilization of free fatty acids into 
the blood. The lack of insulin would produce an increased concentration of 
free fatty acids by mobilizing them and not allowing them to be removed 
by the normal re-esterification process ( Reiser, Peter, 1967). 
Another action of diabetes, would be a decrease in the rate of 
carbohydrate metabolism. Thirty percent of the dietary carbohydrates are 
stored in adipose tissue. In diabetics, the carbohydrates are not easily 
stored, which causes a decrease in the synthesis of fatty acids by the 
adipose tissue. The fatty acids that are stored there, are hydrolyzed into 
free fatty acids in order to be used as an energy source by the body. This 
may lead to the common symptom in diabetics of metabolic acidosis. 
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A lack of insulin also greatly affects the synthesis of proteins. Insulin 
normally stimulates adipose tissue and muscles to convert amino acids 
into proteins. In the testis, insulin also causes an increase in amino acid 
uptake and conversion into proteins ( Reiser, Peter, 1967). It seems likely 
that insulin is necessary for muscle anabolism. Testosterone, therefore in 
diabetics, may be blocked from increasing muscle mass due to the lack of 
insulin. This may account for the decrease in testis weight, epididymal 
fat pad weight, and skeletal muscle weight in the diabetic animals, 
especially those receiving testosterone (group 2). 
CONCLUSION 
The lack of insulin acts to indirectly inhibit the re-esterification of 
fatty acids. This causes them not to be removed from the blood, therefore 
increasing the plasma concentraion of free fatty acids. Insulin also 
causes the inhibition of many hormones. These hormones normally 
mobilize fatty acids into the blood. Since the hormones are not inhibited 
in diabetics, the increased rate of mobilization results in increased levels 
of plasma free fatty acids. Diabetes also decreases the storage rate of 
free fatty acids allowing them to build up in the blood. The lack of insulin 
may also cause a decrease in muscle anabolism. Testosterone, which 
normally builds muscle, may not be able to do so without insulin. 
Testosterone also mobilizes fatty acids causing increased levels in the 
blood. The actions of the body caused by the lack of insulin, in addition to 
the actions of testosterone may be synergistic. They cause an increased 
level of free fatty acids in the blood. One study has shown, that normal 
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tissues can be made to behave like tissues from diabetic animals by 
raising the free fatty acids concentration of the medium which bathes the 
tissues ( Reiser, Peter, 1967). Exogenous testosterone may raise the 
plasma free fatty acid concentration of the blood enough to potentiate 
diabetes in the living tissues of the male rat. The endogenous 
testosterone of the male may explain why males are more prone to 
developing diabetes. 
There are many other studies which can stem from this experiment. 
Examining the direct levels of plasma free fatty acids throughout the 
experiment would most definately provide useful information. Also 
studying treatment with nicotinic acid would be interesting. Nicotinic 
acid inhibits free fatty acid mobilization ( Crepaldi, G. 1985). The effects 
of growth hormone and ACTH may also play a role in the process. 
Advanced studies on this topic may need to consider these effects. Also, 
measuring the cholesterol, VLDL, HDL, and LDL levels in the blood would be 
of interest. Monitoring the activity of the hormones and enzymes which 
participate may also be of use. Overall much more in depth research is 
needed to conclusively prove the mechanism of action suggested here. 
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